Seizures in alcohol withdrawal syndrome

被引:0
|
作者
Lasocka, Magdalena [1 ]
Konopko, Magdalena [1 ]
Basinska-Szafranska, Anna [2 ]
Rogowski, Artur [3 ]
Sienkiewicz-Jarosz, Halina [1 ]
机构
[1] Inst Psychiatrii & Neurol, Klin Neurologiczna 1, Warsaw, Poland
[2] Inst Psychiatrii & Neurol, Zespol Profilaktyki & Leaenia Uzaleznien, Poradnia Zdrowia Psychicznego, Warsaw, Poland
[3] Inst Matki & Dziecka, Klin Poloznictwa & Ginekol, Warsaw, Poland
来源
AKTUALNOSCI NEUROLOGICZNE | 2020年 / 20卷 / 02期
关键词
alcohol withdrawal syndrome; epileptic seizures; treatment; MANAGEMENT; BENZODIAZEPINES; DIAZEPAM; MECHANISMS; LORAZEPAM; DELIRIUM;
D O I
10.15557/AN.2020.0008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alcohol withdrawal syndrome develops in individuals with alcohol dependence who discontinue or reduce alcohol intake after long-term or binge drinking. Withdrawal symptoms usually occur 6-8 hours after the last alcohol consumption and peak between 24-72 hours. Typical manifestations include tremor, nausea, vomiting, insomnia, agitation, and excess sweating. Complicated withdrawal syndrome may manifest with seizures (including cluster seizures), status epilepticus, acute psychosis and delirium, when hallucinations are accompanied by disorientation in time, place and situation. About 10-15% of patients develop complicated withdrawal syndrome. The seizures in alcohol withdrawal syndrome are triggered in the brain stem and have a mechanism other than that of classic epileptic seizures. Benzodiazepines, which are more effective than other classes of anticonvulsants (they primarily reduce the frequency of convulsions in the first two days after alcohol discontinuation and significantly reduce the risk of death), are the gold standard for the treatment of alcohol withdrawal syndrome. The Clinical Institute of Withdrawal Assessment for Alcohol Scale (CIWA-Ar) is a helpful tool for making decisions on treatment initiation or discontinuation. It should be noted that chronic use of benzodiazepines in the secondary prevention of alcohol withdrawal seizures is not recommended due to the addictive potential of these agents and a more severe course of alcohol withdrawal seizures with benzodiazepine co-dependence.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 50 条
  • [31] Alcohol withdrawal syndrome
    Bayard, M
    McIntyre, J
    Hill, KR
    Woodside, J
    AMERICAN FAMILY PHYSICIAN, 2004, 69 (06) : 1443 - 1450
  • [32] The alcohol withdrawal syndrome
    McKeon, A.
    Frye, M. A.
    Delanty, Norman
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (08): : 854 - 862
  • [33] Alcohol Withdrawal Syndrome
    Carlson, Richard W.
    Kumar, Nivedita N.
    Wong-Mckinstry, Edna
    Ayyagari, Srikala
    Puri, Nitin
    Jackson, Frank K.
    Shashikumar, Shivaramaiah
    CRITICAL CARE CLINICS, 2012, 28 (04) : 549 - +
  • [34] ALCOHOL WITHDRAWAL SYNDROME
    LANDERS, DF
    AMERICAN FAMILY PHYSICIAN, 1983, 27 (05) : 114 - 118
  • [35] A study of gabapentine (Torrex) in the treatment of tonic-clonic seizures of alcohol withdrawal syndrome
    Rustembegovic, A
    Kundurovic, Z
    Sofic, E
    EPILEPSIA, 2003, 44 : 174 - 174
  • [36] PREVENTION OF ALCOHOL WITHDRAWAL SEIZURES WITH PHENYTOIN IN RATS
    CHU, NS
    EPILEPSIA, 1981, 22 (02) : 179 - 184
  • [37] CDT and homocysteine as predictors for alcohol withdrawal seizures
    Hintzen, A.
    Cramer, J.
    Karaguelle, D.
    Frieling, H.
    Bleich, S.
    Hillemacher, T.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 222 - 222
  • [38] ALCOHOL WITHDRAWAL SEIZURES - PREVALENCE AND POSSIBLE PREDICTORS
    SOYKA, M
    LUTZ, W
    NERVENHEILKUNDE, 1989, 8 (03) : 114 - 120
  • [39] Alcohol withdrawal seizures, epilepsy and brain trauma
    Dzhupanov, G.
    Nikolov, V.
    Slaveykov, G.
    EUROPEAN PSYCHIATRY, 2024, 67 : S401 - S401
  • [40] Plasma homocysteine is a predictor of alcohol withdrawal seizures
    Bleich, S
    Degner, D
    Bandelow, B
    von Ahsen, N
    Rüther, E
    Kornhuber, J
    NEUROREPORT, 2000, 11 (12) : 2749 - 2752